ELIZABETH ONYEJEKWE: Open Payments
NPI 1275145930 · WOODBRIDGE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$592 in 18 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $59 · 2025 $592
Food & beverage: $592
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $340 |
| Neuronetics, Inc. | 2 | $73 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $48 |
| Otsuka America Pharmaceutical, Inc. | 2 | $47 |
| Neurocrine BioSciences, Inc. | 1 | $35 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $28 |
| Vanda Pharmaceuticals Inc. | 1 | $21 |
Products named: VRAYLAR, QULIPTA, NEUROSTAR TMS THERAPY SYSTEM, ABILIFY MAINTENA, CAPLYTA, INGREZZA, REXULTI, HETLIOZ.
Industry payments across VA — which companies pay providers there.
